A large body of evidence has implicated amyloid precursor protein (APP) and itsproteolytic derivatives as key players in the physiological context of neuronalsynaptogenesis and synapse maintenance, as well as in the pathology ofAlzheimer's Disease (AD). The gene discussed is APP; the disease is glycogen storage disease VI.